J&J hit by "excessive" $8 bln verdict

Analysts termed "excessive" the $8 billion a jury ordered Johnson & Johnson to pay to a man who said the antipsychotic drug Risperdal caused him to grow breasts. Fred Katayama reports.

Multimedia

Most Popular Videos